Search

You searched for "impairment"

1962 results found

Lord Trees and Baroness Sugg call to end Neglected Tropical Diseases with charity coalition at Westminster event

9 June 2022
UK Coalition against Neglected Tropical Diseases works alongside co-host parliamentary reception in the House of Lords.

Understanding and confronting bacterial endophthalmitis

2 December 2019 | | EYE - Cornea, EYE - Vitreo-Retinal, EYE - General
Abdus Samad Ansari highlights the importance of early recognition of this condition using an unusual presentation. Endophthalmitis is a medical emergency with devastating consequences. Despite adequate treatment, severe cases frequently result in permanent blindness. Endophthalmitis involves inflammation of both the...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

Michael Burdon to begin term of office as a BCPB Trustee

17 June 2020
Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.

British Council for Prevention of Blindness has a new Chairman

9 November 2020
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.

DR-NET National DR Workshop in Tanzania: Policy, training and technology

4 August 2025 | | EYE - Imaging, EYE - Vitreo-Retinal
Diabetic retinopathy (DR) is a leading cause of moderate to severe visual impairment (VI) and blindness worldwide, posing a significant public health challenge. As the prevalence of diabetes continues to rise globally, particularly in low- and middle-income countries (LMICs), the...

Tackling diabetic retinopathy globally through the VISION 2020 LINKS Diabetic Retinopathy Network

1 February 2017 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
It is abundantly clear that the burden of diabetes is rapidly increasing, as there are now 415 million adults with diabetes in the world, with a projected rise to 642 million by 2040 [1]. This equates to 1 in 10...

2023 International Myopia Institute White Papers Released in Special Edition of IOVS

9 May 2023 | myopia, White Papers, IMI, IOVS
The International Myopia Institute (IMI) is excited to announce the release of the third series of their highly cited White Papers in a special issue of the top peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.

There will be a 27% rise in the number of people living with sight loss in the UK by 2035, RNIB the UK’s leading sight loss charity predicts

20 October 2024 | charity, international, government, call to action, UK, local, sight loss, statistics
This World Sight Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) was calling for the UK Government to prioritise eye health. This is after fresh insight from the charity that shows there will be a...

Moorfields Eye Charity appoints Louise Robertshaw as trustee

29 January 2025 | charity, moorfields, Appointments, Industry, Fundraising
Louise Robertshaw has been appointed as a trustee at Moorfields Eye Charity. She will also chair the charity’s fundraising and communications committee. Louise has considerable experience working at a senior level and as a trustee at national charities including in...

Specialty-driven EMR for paperless clinical environment – insights for an informed choice

1 August 2016 | | EYE - General
Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...